MedPath

comparison of effects of nebulised Frusemide and placebi in patients with acute dyspnea transmited by EMS

Phase 3
Recruiting
Conditions
acute dyspnea.
Dyspnea
Registration Number
IRCT20171014036753N2
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
150
Inclusion Criteria

all patient between 18 to 75 years old with dyspnea who transmitted to hospitals by EMS

Exclusion Criteria

not willing to participate in the study
history of susceptibility to sulfa drugs
unstable hemodynamics; requiring mechanical ventilation; decreased consciousness, accompany with another illness requiring treatment in the first 10 minutes of treatment with digoxin, beta blocker, beta-agonist and calcium; need to have another inhaling treatment in the first 10 minutes and need to have non-invasive ventilation.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath